Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China

SHANGHAI, March 23, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,...

Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited

Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited

SHANGHAI, March 18, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,...

Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy

Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy

TAIPEI and SAN DIEGO, March 18, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that...

XCL Education Enters Thailand's Eastern Economic Corridor with Mooltripakdee Partnership

XCL Education Enters Thailand's Eastern Economic Corridor with Mooltripakdee Partnership

SINGAPORE and PATTAYA, Thailand, March 17, 2026 /PRNewswire/ -- XCL Education ("XCL"), one of Southeast Asia's leading K-12 education platforms, has entered a strategic partnership with Mooltripakdee International School (MIS) in Chonburi, Thailand...

Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance

Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance

HONG KONG, March 16, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispecific antibody, AK150 (ILT2/ILT4/CSF1R), has received Investigational New Drug (IND) clearance from...

World's First Self-Balancing Motorcycle OMO X Enters Mass Production: A New Era for Smart Two-Wheelers

World's First Self-Balancing Motorcycle OMO X Enters Mass Production: A New Era for Smart Two-Wheelers

SINGAPORE, March 13, 2026 /PRNewswire/ -- At the 2026 Global Technology Launch held at Jewel Changi Airport's Canopy Park, OMOWAY announced that its flagship self-balancing electric motorcycle, the OMO X, has officially entered mass production, with...

Hong Leong Islamic Bank Enters New Era as "HLB Islamic", Charts New Course in Wealth Stewardship with 'Hayat' Proposition

Hong Leong Islamic Bank Enters New Era as "HLB Islamic", Charts New Course in Wealth Stewardship with 'Hayat' Proposition

With the refreshed brand identity and strengthened core proposition, HLB Islamic is empowering customers to view every financial decision through a Shariah-guided wealth lifecycle approach KUALA LUMPUR, Malaysia, March 12, 2026 /PRNewswire/ -- As a...

MDJM LTD Announces Journey to the West Officially Enters Production

MDJM LTD Announces Journey to the West Officially Enters Production

A Prestigious European Production Team Leads the Project LONDON, March 2, 2026 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that the animated short...

WuXi XDC Enters Strategic Collaboration with Earendil Labs on WuXiTecan-2 Payload-Linker Technology Platform

WuXi XDC Enters Strategic Collaboration with Earendil Labs on WuXiTecan-2 Payload-Linker Technology Platform

SHANGHAI, Feb. 27, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other...

Earendil Labs Enters Strategic Collaboration with WuXi XDC on WuXiTecan-2 Payload-Linker Technology Platform

Earendil Labs Enters Strategic Collaboration with WuXi XDC on WuXiTecan-2 Payload-Linker Technology Platform

WILMINGTON, Del., Feb. 27, 2026 /PRNewswire/ -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, today announced a strategic collaboration with WuXi XDC Cayman Inc. ("WuXi XDC", stock...

  • 1
  • 2
  • 3
  • 4
  • menu
    menu